流传的病毒性呼吸道病原体作为摩洛哥严重急性呼吸道感染的致病因子:系统性综述
Kharbach Ahmed1,2,3, Baba Mohamed Amine2,3,4, Oubaasri Ahmed5,6
1Laboratory of Biostatistics, Clinical Research and Epidemiology, Faculty of Medicine and Pharmacy of Rabat, Mohamed V University, Rabat 10100, Morocco.
African journal of infectious diseases
|November 21, 2025
概括
这项研究评估了摩洛哥呼吸道病毒的流行情况,发现急性呼吸道感染患者中流行性流感A ((H1N1) 2009年,季节性流感,呼吸道共囊病毒和犀牛病毒的严重率.
科学领域:
- 医学微生物学 医学微生物学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 急性呼吸道感染 (ARI) 常常是由各种微生物引起的,越来越多地强调病毒病原体.
- 严重急性呼吸道感染的出现加剧了对病毒作为重要的ARI代理物的关注.
- 了解病毒患病率对于公共卫生策略和ARI的临床管理至关重要.
研究的目的:
- 评估在摩洛哥不同地区被诊断患有急性呼吸道感染的患者中关键呼吸道病毒的流行情况.
- 通过系统性审查,综合摩洛哥ARI病毒病因的现有数据.
- 为了解摩洛哥人口中特定呼吸道病毒的负担提供见解.
主要方法:
- 按照PRISMA指南进行了系统审查.
- 在PubMed,Scopus,ScienceDirect和Web of Science数据库中进行文献搜索,搜索2000年至2023年间发表的研究.
- 在查后的最终分析中,包括了23项相关研究.
主要成果:
- 2009年流行性流感A ((H1N1) 流行率差异很大 (8%96%),大多数研究报告超过30%.
- 季节性流感的流行率在0.88%至17%之间.
- 呼吸道同胞性病毒 (RSV) 患病率在儿童中为18%36.47%,在所有年龄组中为12%53.8%. 在一些研究中,犀牛病毒的流行率在儿童中超过了50%,在一般人群中从5.8%到38%不等.
结论:
- 流行性流感,季节性流感,呼吸道共囊病毒和犀牛病毒在摩洛哥急性呼吸道感染患者中普遍存在.
- 这些发现凸显了这些病毒在摩洛哥ARI病因学中的重要作用.
- 这些数据强调了该地区对呼吸道病毒感染的持续监测和有针对性的干预措施的需要.
相关概念视频
Common Respiratory Disorders
1.3K
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.3K
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Drugs Used in Upper Respiratory Disorders: Overview
609
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
609
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K


